Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to compare the effect of farletuzumab versus placebo in combination with either a platinum agent (carboplatin) with paclitaxel or a platinum agent (carboplatin o...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Morphotek
NCT02264210 · Lung Neoplasms, Squamous Cell Lung Cancer, and more
NCT04046614 · Adenocarcinoma of the Lung
NCT01958372 · Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, and more
NCT01259089 · Adenocarcinoma of the Lung, Non-small Cell Lung Cancer
NCT02466568 · Lung Cancer, Adenocarcinoma of the Lung
Ironwood Cancer and Research Center
Chandler, Arizona
Arizona Center for Hematology Oncology
Glendale, Arizona
Providence Health System
Beverly Hills, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions